Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Amyloidosis Channel on VJHemOnc is an independent medical education platform, supported with funding from Prothena (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.

Share this video  

VJVirtual | TOURMALINE-AL1: ixazomib-dexamethasone for AL amyloidosis

Ashutosh Wechalekar • 17 Jul 2020
Amyloidosis Rare Diseases Dexamethasone Ixazomib
TOURMALINE-AL1

Ashutosh Wechalekar, MBBS, FRCP, FRCPath, University College London Hospitals NHS Trust, London, UK, discusses findings from the Phase III TOURMALINE-AL1 study (NCT01659658), evaluating ixazomib and dexamethasone in the treatment of amyloid light-chain (AL) amyloidosis. This interview was recorded via an online conference call with the Video Journal of Hematological Oncology (VJHemOnc).

More from Ashutosh Wechalekar

Advances in the treatment and diagnosis of amyloidosis: what does the future hold? 1:36
Advances in the treatment and diagnosis of amyloidosis: what does the future hold?
Ashutosh Wechalekar • 13 Jun 2025
Treatment strategies for patients with R/R amyloidosis: targeting BCL2 or BCMA 1:34
Treatment strategies for patients with R/R amyloidosis: targeting BCL2 or BCMA
Ashutosh Wechalekar • 13 Jun 2025
Hidden light chain amyloidosis in patients with multiple myeloma 1:45
Hidden light chain amyloidosis in patients with multiple myeloma
Ashutosh Wechalekar • 13 Jun 2025
Results of the Phase III AFFIRM-AL trial of birtamimab in AL amyloidosis 1:12
Results of the Phase III AFFIRM-AL trial of birtamimab in AL amyloidosis
Ashutosh Wechalekar • 14 Jun 2025

Related Videos

Refining the diagnosis and classification of CMML 6:25
Refining the diagnosis and classification of CMML
Guillermo Montalban-Bravo et al. • 20 Sep 2025
Improving the diagnosis of amyloidosis: advice that can be applied in practice 2:48
Improving the diagnosis of amyloidosis: advice that can be applied in practice
Gareth Morgan • 18 Sep 2025
Ongoing research in gray zone lymphoma 1:07
Ongoing research in gray zone lymphoma
Kieron Dunleavy • 4 Sep 2025
Insights into gray zone lymphoma: a rare subtype of NHL 1:14
Insights into gray zone lymphoma: a rare subtype of NHL
Kieron Dunleavy • 4 Sep 2025
The content of VJHemOnc is intended for healthcare professionals